174 related articles for article (PubMed ID: 38433536)
21. [Growth hormone: who can benefit from it?].
Schwarz HP
Ther Umsch; 1995 Oct; 52(10):678-81. PubMed ID: 7482379
[TBL] [Abstract][Full Text] [Related]
22. The role and future challenges for recombinant growth hormone therapy to promote growth in children after renal transplantation.
Janjua HS; Mahan JD
Clin Transplant; 2011; 25(5):E469-74. PubMed ID: 21554398
[TBL] [Abstract][Full Text] [Related]
23. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of recombinant growth hormone treatment in children with growth retardation related to long-term glucocorticosteroid therapy.
Basmaison O; Ranchin B; Zouater H; Robertson A; Gomez R; Koppiker N
Ann Endocrinol (Paris); 2019 Sep; 80(4):202-210. PubMed ID: 30910221
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone use in children with idiopathic short stature.
Weise KL; Nahata MC
Ann Pharmacother; 2004 Sep; 38(9):1460-8. PubMed ID: 15266039
[TBL] [Abstract][Full Text] [Related]
26. Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy.
Mohn A; Marzio D; Giannini C; Capanna R; Marcovecchio M; Chiarelli F
Clin Endocrinol (Oxf); 2005 Nov; 63(5):537-42. PubMed ID: 16268806
[TBL] [Abstract][Full Text] [Related]
27. Treatment of growth hormone deficient patients with recombinant somatropin for 1 year: results of a Chinese multicentre trial.
Shi YF; Bao XL; Wang DF; Chen RG; Chun Y
Acta Paediatr Scand Suppl; 1990; 370():212-5. PubMed ID: 2260454
[TBL] [Abstract][Full Text] [Related]
28. Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age.
Schwarz HP; Walczak M; Birkholz-Walerzak D; Szalecki M; Nanu M; Woehling H; Schuck E
Adv Ther; 2016 Mar; 33(3):423-34. PubMed ID: 26886776
[TBL] [Abstract][Full Text] [Related]
29. [Attempt to use the genetically engineered growth hormone SAIZEN in children with somatotropic insufficiency: results of clinical trials in Russia].
Dedov II; Peterkova VA; Goncharov NP; Buraia TI; Fofanova OV; Pankova SS; Bukhman AI
Probl Endokrinol (Mosk); 1994; 40(6):30-4. PubMed ID: 7740034
[TBL] [Abstract][Full Text] [Related]
30. The history, physiology and treatment safety of growth hormone.
Tidblad A
Acta Paediatr; 2022 Feb; 111(2):215-224. PubMed ID: 34028879
[TBL] [Abstract][Full Text] [Related]
31. Human growth hormone and other proteins prepared by recombinant DNA technology.
Blethen SL; Weldon VV
Am J Dis Child; 1982 Aug; 136(8):669-71. PubMed ID: 7102615
[No Abstract] [Full Text] [Related]
32. Growth hormone treatment in non-growth hormone-deficient short children.
Loche S; Casini MR; Ubertini GM; Cappa M
J Endocrinol Invest; 2005 Feb; 28(2):193-8. PubMed ID: 15887870
[TBL] [Abstract][Full Text] [Related]
33. Clinical experience with Genotropin worldwide: an update March 1987.
Gunnarsson R; Wilton P
Acta Paediatr Scand Suppl; 1987; 337():147-52. PubMed ID: 3324636
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of intermittent therapy in growth hormone-deficient children.
Bougnères P
Eur J Endocrinol; 1994 May; 130(5):459-62. PubMed ID: 8180672
[TBL] [Abstract][Full Text] [Related]
35. Technology spurt resolves growth hormone problem, ends shortage.
Glasbrenner K
JAMA; 1986 Feb; 255(5):581-4, 587. PubMed ID: 3511309
[No Abstract] [Full Text] [Related]
36. Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial.
Maniatis AK; Nadgir U; Saenger P; Reifschneider KL; Abuzzahab J; Deeb L; Fox LA; Woods KA; Song W; Mao M; Chessler SD; Komirenko AS; Shu AD; Casella SJ; Thornton PS
Horm Res Paediatr; 2022; 95(3):233-243. PubMed ID: 35263755
[TBL] [Abstract][Full Text] [Related]
37. [The evaluation of the influence of growth hormone therapy on growing process and metabolic functions in patients after treatment of craniopharyngioma].
Okońska M; Birkholz D; Korpal-Szczyrska M; Adamkiewicz-Drozyńska E; Alska A; Magnuszewska H
Pediatr Endocrinol Diabetes Metab; 2010; 16(1):19-24. PubMed ID: 20529601
[TBL] [Abstract][Full Text] [Related]
38. Somatropin: increased mortality?
Prescrire Int; 2011 Jun; 20(117):153. PubMed ID: 21678705
[No Abstract] [Full Text] [Related]
39. [Effects of human growth hormone on very short children with intermediate responses to somatotropic stimulation tests].
Job JC; Rolland A; Garnier PE; Chaussain JL
Arch Fr Pediatr; 1985 May; 42(5):353-7. PubMed ID: 4074087
[TBL] [Abstract][Full Text] [Related]
40. Human growth hormone therapy: longterm responses in 30 children with growth hormone deficiency.
Kannan V; Usharani K
Indian J Pediatr; 1991; 58 Suppl 1():65-9. PubMed ID: 1824378
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
